Variant · Snv
B3GLCT NM_194318.4(B3GLCT):c.1105G>A (p.Gly369Ser)
CI-VAR-00047450Explore in graph →p.Gly369SerNM_194318.4:c.1105G>AClinVar 263091 rs34638481
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 263091 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Peters plus syndrome; Uterine corpus endometrial carcinoma; Colon adenocarcinoma; Hepatocellular carcinoma; Cervical cancer; Uveal melanoma; Colorectal cancer; Acute myeloid leukemia; Nonpapillary renal cell carcinoma; Sarcoma; Uterine carcinosarcoma; Thymoma; Thyroid cancer, nonmedullary, 1 | germline | 8 | Feb 01, 2026 | clinvar |